UTHR vs WY · P/E 20, rev $1.56B vs P/E 43, rev $3.59B
United Therapeutics Corporation (UTHR) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the UTHR and WY stock pages for the full models.
Not investment advice.